{Reference Type}: Case Reports
{Title}: 45,X/46,XX at amniocentesis associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes and in different amniocenteses and a favorable fetal outcome with a normal karyotype at birth.
{Author}: Chen CP;Wu FT;Pan YT;Wu PS;Wang W;
{Journal}: Taiwan J Obstet Gynecol
{Volume}: 62
{Issue}: 4
{Year}: 2023 Jul
{Factor}: 1.944
{DOI}: 10.1016/j.tjog.2023.05.005
{Abstract}: OBJECTIVE: We present 45,X/46,XX at amniocentesis associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes and in different amniocenteses and a favorable fetal outcome with a normal karyotype at birth.
METHODS: A 35-year-old, gravida 3, para 2, woman underwent amniocentesis at 20 weeks of gestation because of advanced maternal age. Amniocentesis revealed a karyotype of 45,X[11]/46,XX[108], consistent with 9.2% mosaicism for 45,X. Prenatal ultrasound findings were unremarkable. She was referred for genetic counseling at 25 weeks of gestation, and repeat amniocentesis at 26 weeks of gestation revealed a karyotype of 45,X[4]/46,XX[16], consistent with 20% mosaicism for 45,X. Simultaneous array comparative genomic hybridization (aCGH) analysis on the DNA extracted from uncultured amniocytes using SurePrint G3 Unrestricted CGH ISCA v2, 8 × 60K (Agilent Technologies, Santa Clara, CA, USA) revealed arr (1-22, X) × 2, Y × 0 with no genomic imbalance. The woman was advised to continue pregnancy, and at 38 weeks of gestation, a healthy 3140-g female baby was delivered with no phenotypic abnormalities. The cord blood had a karyotype of 46,XX (40/40 cells). When follow-up at age two months, the neonate had normal development and a normal karyotype.
CONCLUSIONS: Confirmation of 45,X/46,XX at amniocentesis should include conventional cytogenetic analysis and karyotyping on cultured amniocytes, and sole molecular analysis on uncultured amniocytes may miss the diagnosis of 45,X/46,XX.